Journal
OBSTETRICS AND GYNECOLOGY
Volume 105, Issue 1, Pages 167-173Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.AOG.0000147839.74848.7c
Keywords
-
Categories
Funding
- NCI NIH HHS [N01-CP-51017, N01-CP-21168, N01-CP-01289] Funding Source: Medline
- DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP001289, N01CP021168, N01CP051017] Funding Source: NIH RePORTER
Ask authors/readers for more resources
OBJECTIVE: To investigate the association between prenatal diethylstilbestrol (DES) exposure and risk of benign gynecologic tumors. METHODS: We conducted a collaborative follow-up study of women with and without documented intrauterine exposure to DES. We compared the incidence of self-reported ovarian cysts, paraovarian cysts, and uterine leiomyomata confirmed by medical record in DES-exposed and unexposed women. RESULTS: A total of 85 cases of uterine leiomyomata and 168 cases of ovarian or paraovarian cysts were confirmed histologically. After adjustment for age, no association was found between prenatal DES exposure and ovarian cysts or uterine leiomyomata. Prenatal DES exposure was positively associated with paraovarian cysts. CONCLUSION: The present results do not support the hypothesis that prenatal DES exposure increases risk of uterine leiomyomata or ovarian cysts. Prenatal DES exposure was associated with an increased risk of paraovarian cysts, but detection bias cannot be ruled out as an explanation of this finding. (Obstet Gynecol 2005;105:167-73. (C) 2005 by The American College of Obstetricians and Gynecologists.).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available